|
The Asthma Drug Market Will Remain Relatively Flat, Increasing Slightly from …
PR Newswire (press release) BURLINGTON, Mass., Dec. 18, 2013 /PRNewswire/ — Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the drug market for asthma will remain relatively flat through 2022 … |
View full post on asthma – Google News